National Bank of Canada FI Acquires 44,204 Shares of Intuitive Surgical, Inc. $ISRG

National Bank of Canada FI grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 417,266 shares of the medical equipment provider’s stock after buying an additional 44,204 shares during the period. National Bank of Canada FI owned approximately 0.12% of Intuitive Surgical worth $186,613,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. SteelPeak Wealth LLC raised its position in Intuitive Surgical by 28.7% during the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after purchasing an additional 9,364 shares during the period. Atlantic Union Bankshares Corp boosted its holdings in shares of Intuitive Surgical by 19.3% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock worth $10,179,000 after purchasing an additional 3,676 shares during the period. World Investment Advisors increased its position in shares of Intuitive Surgical by 238.3% during the 3rd quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock valued at $2,415,000 after purchasing an additional 3,803 shares during the last quarter. E. Ohman J or Asset Management AB increased its position in shares of Intuitive Surgical by 4.1% during the 3rd quarter. E. Ohman J or Asset Management AB now owns 28,306 shares of the medical equipment provider’s stock valued at $12,659,000 after purchasing an additional 1,123 shares during the last quarter. Finally, Valley Wealth Managers Inc. raised its holdings in Intuitive Surgical by 52.7% during the 3rd quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock valued at $1,826,000 after buying an additional 1,409 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have commented on ISRG shares. Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday, January 26th. TD Cowen raised shares of Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. HSBC increased their price target on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a report on Monday, January 26th. Finally, Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target for the company in a research note on Wednesday, March 11th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $615.86.

Intuitive Surgical Price Performance

Shares of ISRG opened at $483.46 on Tuesday. The firm has a market capitalization of $171.69 billion, a price-to-earnings ratio of 61.28, a PEG ratio of 3.64 and a beta of 1.66. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $603.88. The company has a 50-day moving average of $511.60 and a 200 day moving average of $513.03.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.21 EPS. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 645 shares of the firm’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total transaction of $312,831.45. Following the transaction, the senior vice president directly owned 1,613 shares in the company, valued at $782,321.13. This trade represents a 28.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president directly owned 660 shares of the company’s stock, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 32,943 shares of company stock worth $17,279,568 over the last three months. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.